Mustafa Ci̇ri̇t

1.2k total citations
35 papers, 830 citations indexed

About

Mustafa Ci̇ri̇t is a scholar working on Nephrology, Pulmonary and Respiratory Medicine and Hematology. According to data from OpenAlex, Mustafa Ci̇ri̇t has authored 35 papers receiving a total of 830 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Nephrology, 9 papers in Pulmonary and Respiratory Medicine and 6 papers in Hematology. Recurrent topics in Mustafa Ci̇ri̇t's work include Chronic Kidney Disease and Diabetes (13 papers), Acute Kidney Injury Research (12 papers) and Dialysis and Renal Disease Management (5 papers). Mustafa Ci̇ri̇t is often cited by papers focused on Chronic Kidney Disease and Diabetes (13 papers), Acute Kidney Injury Research (12 papers) and Dialysis and Renal Disease Management (5 papers). Mustafa Ci̇ri̇t collaborates with scholars based in Türkiye, United States and Germany. Mustafa Ci̇ri̇t's co-authors include Ömer Toprak, Murat Yeşil, Serdar Bayata, R. Ersoy, Nurşen Postacı, Ercan Ok, Mehmet Tanrısev, Gülay Aşçı, Mehmet Özkahya and Fatih Kırçelli and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of the American Society of Nephrology and Nephrology Dialysis Transplantation.

In The Last Decade

Mustafa Ci̇ri̇t

34 papers receiving 779 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mustafa Ci̇ri̇t Türkiye 16 586 191 120 99 91 35 830
Sherry G. Mansour United States 16 438 0.7× 90 0.5× 67 0.6× 230 2.3× 60 0.7× 37 881
Bo Frennby Sweden 16 320 0.5× 185 1.0× 79 0.7× 91 0.9× 33 0.4× 28 711
Danilo Fliser Germany 5 445 0.8× 122 0.6× 103 0.9× 144 1.5× 50 0.5× 7 798
Nurcan Cengız Türkiye 14 338 0.6× 178 0.9× 25 0.2× 92 0.9× 19 0.2× 51 716
L Orte Spain 16 461 0.8× 149 0.8× 51 0.4× 183 1.8× 16 0.2× 37 796
Elke D. Berger Germany 9 344 0.6× 149 0.8× 76 0.6× 298 3.0× 51 0.6× 12 979
Jessie E. Hano United States 13 284 0.5× 197 1.0× 17 0.1× 131 1.3× 29 0.3× 42 708
Cherry Mammen Canada 15 817 1.4× 289 1.5× 119 1.0× 171 1.7× 12 0.1× 50 1.1k
Nigel S. Kanagasundaram United Kingdom 15 380 0.6× 61 0.3× 89 0.7× 149 1.5× 21 0.2× 59 590
Éric Descombes Switzerland 12 343 0.6× 188 1.0× 16 0.1× 98 1.0× 49 0.5× 33 659

Countries citing papers authored by Mustafa Ci̇ri̇t

Since Specialization
Citations

This map shows the geographic impact of Mustafa Ci̇ri̇t's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mustafa Ci̇ri̇t with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mustafa Ci̇ri̇t more than expected).

Fields of papers citing papers by Mustafa Ci̇ri̇t

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mustafa Ci̇ri̇t. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mustafa Ci̇ri̇t. The network helps show where Mustafa Ci̇ri̇t may publish in the future.

Co-authorship network of co-authors of Mustafa Ci̇ri̇t

This figure shows the co-authorship network connecting the top 25 collaborators of Mustafa Ci̇ri̇t. A scholar is included among the top collaborators of Mustafa Ci̇ri̇t based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mustafa Ci̇ri̇t. Mustafa Ci̇ri̇t is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Duman, Neval, Abdullah Uyanık, Alaettin Ünsal, et al.. (2014). Once-monthly continuous erythropoietin receptor activator (CERA) for haemoglobin maintenance in haemodialysis patients with chronic renal anaemia. Clinical Kidney Journal. 7(5). 464–469. 4 indexed citations
2.
Aşçı, Gülay, Hüseyin Töz, Mehmet Özkahya, et al.. (2013). The Impact of Membrane Permeability and Dialysate Purity on Cardiovascular Outcomes. Journal of the American Society of Nephrology. 24(6). 1014–1023. 32 indexed citations
3.
Varol, Umut, et al.. (2013). Association between hyperlactatemia and occult cardiac failure in diabetic patients on maintenance hemodialysis. International Urology and Nephrology. 46(8). 1639–1644. 3 indexed citations
4.
Çakalağaoğlu, Fulya, et al.. (2013). Quantitative evaluation of interstitial fibrosis with Sirius Red in IgA nephritis. Renal Failure. 36(1). 73–77. 2 indexed citations
5.
Ci̇ri̇t, Mustafa, et al.. (2012). The Value of Serum Immunoglobulin Free Light Chain Assessment in Patients with Monoclonal Gammopathies and Acute Renal Failure. SHILAP Revista de lepidopterología. 29(4). 385–391. 1 indexed citations
6.
Ersoy, R., et al.. (2012). Glomerular C4d Staining Can Be an Indicator of Disease Activity in Lupus Nephritis. Renal Failure. 35(2). 222–225. 14 indexed citations
7.
Koç, Mehmet, Turgay Arınsoy, Zeki Tonbul, et al.. (2011). Statin use is associated with lower inflammation and erythropoietin responsiveness index in hemodialysis patients. Hemodialysis International. 15(3). 366–373. 11 indexed citations
8.
Avcı, Eyüp, et al.. (2011). The role of nebivolol in the prevention of contrast-induced nephropathy in patients with renal dysfunction. Anadolu Kardiyoloji Dergisi/The Anatolian Journal of Cardiology. 11(7). 613–7. 18 indexed citations
9.
10.
Toprak, Ömer, Mustafa Ci̇ri̇t, Mehmet Tanrısev, et al.. (2007). Preventive effect of nebivolol on contrast-induced nephropathy in rats. Nephrology Dialysis Transplantation. 23(3). 853–859. 89 indexed citations
11.
Toprak, Ömer, et al.. (2007). An Unusual Vascular Involvement in a Patient With Behcet’s Disease: Renal Artery Stenosis. The American Journal of the Medical Sciences. 334(5). 396–398. 5 indexed citations
12.
Toprak, Ömer & Mustafa Ci̇ri̇t. (2006). Risk Factors for Contrast-Induced Nephropathy. Kidney & Blood Pressure Research. 29(2). 84–93. 59 indexed citations
13.
Toprak, Ömer & Mustafa Ci̇ri̇t. (2006). Risk Factors and Therapy Strategies for Contrast-Induced Nephropathy. Renal Failure. 28(5). 365–381. 15 indexed citations
14.
Ci̇ri̇t, Mustafa, Ömer Toprak, Murat Yeşil, et al.. (2006). Angiotensin-Converting Enzyme Inhibitors as a Risk Factor for Contrast-Induced Nephropathy. Nephron Clinical Practice. 104(1). c20–c27. 77 indexed citations
15.
Toprak, Ömer, Mustafa Ci̇ri̇t, Murat Yeşil, et al.. (2006). Metabolic Syndrome as a Risk Factor for Contrast-Induced Nephropathy in Non-Diabetic Elderly Patients with Renal Impairment. Kidney & Blood Pressure Research. 29(1). 2–9. 23 indexed citations
16.
Toprak, Ömer, et al.. (2006). Hyperuricemia as a risk factor for contrast‐induced nephropathy in patients with chronic kidney disease. Catheterization and Cardiovascular Interventions. 67(2). 227–235. 51 indexed citations
17.
Toprak, Ömer, Mustafa Ci̇ri̇t, Murat Yeşil, et al.. (2006). Impact of diabetic and pre-diabetic state on development of contrast-induced nephropathy in patients with chronic kidney disease. Nephrology Dialysis Transplantation. 22(3). 819–826. 74 indexed citations
18.
Toprak, Ömer, et al.. (2003). Koroner anjiyografi yapılan hastalarda işlem öncesi verilen kaptoprilin kontrast madde nefropatisi üzerine etkisinin araştırılması. 3(2). 98–103. 24 indexed citations
19.
Toprak, Ömer, et al.. (2003). Koroner Anjiyografi Yapılan Hastalarda Sol Ventrikül Ejeksiyon Fraksiyonu Ile Kontrast Madde Nefropatisi Gelişmesi Arasında İlişki Var Mıdır. Turkiye Klinikleri Tip Bilimleri Dergisi. 23(2). 104–107. 2 indexed citations
20.
Ok, Ercan, Fehmi Akçiçek, Murat Tombuloğlu, et al.. (1995). Alloimmune haemolytic anaemia after renal transplantation.. PubMed. 10(3). 404–5. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sherry G. Mansour Breakdown of academic impact, for papers by Bo Frennby Breakdown of academic impact, for papers by Danilo Fliser Breakdown of academic impact, for papers by Nurcan Cengız Breakdown of academic impact, for papers by L Orte Breakdown of academic impact, for papers by Elke D. Berger Breakdown of academic impact, for papers by Jessie E. Hano Breakdown of academic impact, for papers by Cherry Mammen Breakdown of academic impact, for papers by Nigel S. Kanagasundaram Breakdown of academic impact, for papers by Éric Descombes
Rankless by CCL
2026